Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis
What's known on the subject? and What does the study add? Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increas...
Saved in:
Published in | BJU international Vol. 111; no. 4; pp. 622 - 627 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Wiley-Blackwell
01.04.2013
|
Subjects | |
Online Access | Get full text |
ISSN | 1464-4096 1464-410X 1464-410X |
DOI | 10.1111/j.1464-410X.2012.11292.x |
Cover
Loading…
Abstract | What's known on the subject? and What does the study add?
Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases.
The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β‐crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity.
Objective
To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis.
Material and Methods
A cross‐sectional study of 115 patients in eastern Andalusia, Spain was conducted.
The patients were divided into two groups: Group A: 56 patients aged 25–60 years without calcium renal lithiasis; Group B: 59 patients aged 25–60 years, presenting with calcium renal lithiasis and severe lithogenesis.
The citrate levels and the calcium : citrate ratio in the patients’ urine and the relationship of these two factors to lithiasic activity were analysed and compared.
Results
In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02).
The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005).
The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%).
After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T‐score values of patients.
Conclusions
The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density.
The calcium : citrate ratio, which is linearly related to the bone resorption marker β‐crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25. |
---|---|
AbstractList | What's known on the subject? and What does the study add?
Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases.
The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β‐crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity.
Objective
To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis.
Material and Methods
A cross‐sectional study of 115 patients in eastern Andalusia, Spain was conducted.
The patients were divided into two groups: Group A: 56 patients aged 25–60 years without calcium renal lithiasis; Group B: 59 patients aged 25–60 years, presenting with calcium renal lithiasis and severe lithogenesis.
The citrate levels and the calcium : citrate ratio in the patients’ urine and the relationship of these two factors to lithiasic activity were analysed and compared.
Results
In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02).
The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005).
The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%).
After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T‐score values of patients.
Conclusions
The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density.
The calcium : citrate ratio, which is linearly related to the bone resorption marker β‐crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25. Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases. The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β-crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity.UNLABELLEDDifferent studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases. The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β-crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity.To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis.OBJECTIVETo analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis.A cross-sectional study of 115 patients in eastern Andalusia, Spain was conducted. The patients were divided into two groups: Group A: 56 patients aged 25-60 years without calcium renal lithiasis; Group B: 59 patients aged 25-60 years, presenting with calcium renal lithiasis and severe lithogenesis. The citrate levels and the calcium : citrate ratio in the patients' urine and the relationship of these two factors to lithiasic activity were analysed and compared.MATERIAL AND METHODSA cross-sectional study of 115 patients in eastern Andalusia, Spain was conducted. The patients were divided into two groups: Group A: 56 patients aged 25-60 years without calcium renal lithiasis; Group B: 59 patients aged 25-60 years, presenting with calcium renal lithiasis and severe lithogenesis. The citrate levels and the calcium : citrate ratio in the patients' urine and the relationship of these two factors to lithiasic activity were analysed and compared.In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02). The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005). The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%). After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T-score values of patients.RESULTSIn Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02). The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005). The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%). After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T-score values of patients.The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density. The calcium : citrate ratio, which is linearly related to the bone resorption marker β-crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25.CONCLUSIONSThe patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density. The calcium : citrate ratio, which is linearly related to the bone resorption marker β-crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25. Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases. The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β-crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity. To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis. A cross-sectional study of 115 patients in eastern Andalusia, Spain was conducted. The patients were divided into two groups: Group A: 56 patients aged 25-60 years without calcium renal lithiasis; Group B: 59 patients aged 25-60 years, presenting with calcium renal lithiasis and severe lithogenesis. The citrate levels and the calcium : citrate ratio in the patients' urine and the relationship of these two factors to lithiasic activity were analysed and compared. In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02). The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005). The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%). After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T-score values of patients. The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density. The calcium : citrate ratio, which is linearly related to the bone resorption marker β-crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25. Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases.The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased beta -crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity. To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis. A cross-sectional study of 115 patients in eastern Andalusia, Spain was conducted.The patients were divided into two groups: Group A: 56 patients aged 25-60 years without calcium renal lithiasis; Group B: 59 patients aged 25-60 years, presenting with calcium renal lithiasis and severe lithogenesis.The citrate levels and the calcium : citrate ratio in the patients' urine and the relationship of these two factors to lithiasic activity were analysed and compared. In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02).The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005).The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%).After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T-score values of patients. The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density.The calcium : citrate ratio, which is linearly related to the bone resorption marker beta -crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25. |
Author | Arrabal‐Polo, Miguel Angel Arrabal‐Martin, Miguel Poyatos‐Andujar, Antonio Garrido‐Gomez, Juan Arias‐Santiago, Salvador Zuluaga‐Gomez, Armando |
Author_xml | – sequence: 1 givenname: Miguel Angel surname: Arrabal‐Polo fullname: Arrabal‐Polo, Miguel Angel organization: San Cecilio University Hospital – sequence: 2 givenname: Miguel surname: Arrabal‐Martin fullname: Arrabal‐Martin, Miguel organization: San Cecilio University Hospital – sequence: 3 givenname: Salvador surname: Arias‐Santiago fullname: Arias‐Santiago, Salvador organization: University of Granada – sequence: 4 givenname: Juan surname: Garrido‐Gomez fullname: Garrido‐Gomez, Juan organization: San Cecilio University Hospital – sequence: 5 givenname: Antonio surname: Poyatos‐Andujar fullname: Poyatos‐Andujar, Antonio organization: San Cecilio University Hospital – sequence: 6 givenname: Armando surname: Zuluaga‐Gomez fullname: Zuluaga‐Gomez, Armando organization: San Cecilio University Hospital |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27220563$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22757744$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkctu1DAUhi1URC_wCsibSmxm8C3xhAUSVG0pqsSGSuwsxzmmHiXOYGfoZdUtr8mT9GQ6oRKrsWT76Pd3jqX_PyR7sY9ACOVsznG9X865KtVMcfZjLhgXqIpKzG9fkIN_D3tTzapynxzmvGQMhbJ4RfaF0IXWSh2Q-4tu1afBRge099SFIdkBqI0NHa6BOtu6sO7-Pvz5gHt6xSP0NES6wgLikOlNGK4nmCaItqUtSsHmkDfDMvyGBBux_wkRUH9NXnrbZnizvY_I1dnp95Mvs8tv5xcnny5nTkkpZqJpeO2aCqxwleeFU3qhZKG4Vwg0lWS29hq85o3z0NhSi9paVVQ1VzX2yCPy7mnuKvW_1pAH04XsoG1thH6dDZeFEAtZFXoHVCi5UEILRN9u0XXdQWNWKXQ23ZnJWgSOt4DN6IxP6HHIz5wWghWlRO7jE-dSn3MCb9Dm0eCIZofWcGbGzM3SjHGaMVozZm42mZtbHLD4b8D0xw6t279vQgt3O_eZz1-vNqV8BJB2x0Y |
CitedBy_id | crossref_primary_10_1007_s00467_020_04754_6 crossref_primary_10_1007_s00467_020_04693_2 crossref_primary_10_1002_14651858_CD011252_pub2 crossref_primary_10_1155_2017_5391832 crossref_primary_10_1007_s11255_016_1361_5 crossref_primary_10_1039_C5AN00033E crossref_primary_10_1186_s12894_018_0430_8 crossref_primary_10_1186_s12894_020_00749_5 crossref_primary_10_1097_MOU_0000000000000111 crossref_primary_10_1371_journal_pone_0177329 crossref_primary_10_1007_s11255_023_03662_6 crossref_primary_10_1002_14651858_CD011252 crossref_primary_10_1016_j_urology_2015_01_019 crossref_primary_10_1016_j_acuro_2012_10_003 crossref_primary_10_1039_C5CC08759G crossref_primary_10_1111_jpc_15770 crossref_primary_10_1007_s11255_015_0918_z |
Cites_doi | 10.2741/1119 10.1590/S1677-55382005000100006 10.1007/s11255-009-9599-9 10.1159/000189140 10.1016/j.ucl.2007.04.007 10.1016/j.ucl.2007.04.009 10.1002/jbmr.5650091004 10.1016/S0022-5347(05)67487-3 10.1111/j.1464-410X.2011.10167.x 10.5414/CNP63188 10.1159/000473606 10.1016/j.urology.2009.09.084 10.1016/j.urology.2010.01.036 10.1016/S0022-5347(05)64825-2 |
ContentType | Journal Article |
Copyright | 2012 BJU International 2014 INIST-CNRS 2012 BJU International. |
Copyright_xml | – notice: 2012 BJU International – notice: 2014 INIST-CNRS – notice: 2012 BJU International. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7QP |
DOI | 10.1111/j.1464-410X.2012.11292.x |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Calcium & Calcified Tissue Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Calcium & Calcified Tissue Abstracts |
DatabaseTitleList | MEDLINE - Academic MEDLINE Calcium & Calcified Tissue Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1464-410X |
EndPage | 627 |
ExternalDocumentID | 22757744 27220563 10_1111_j_1464_410X_2012_11292_x BJU11292 |
Genre | article Journal Article Comparative Study |
GeographicLocations | Spain |
GeographicLocations_xml | – name: Spain |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACUHS ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FUBAC G-S G.N GODZA H.X HF~ HGLYW HZI HZ~ IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K RJQFR ROL RX1 SUPJJ SV3 TEORI TUS UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 YFH ZGI ZXP ~IA ~WT AAYXX AEYWJ AGHNM AGYGG CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY 7QP |
ID | FETCH-LOGICAL-c4332-2dd1bcd9ea2c9f15c47843541f4c43d930abf7ef71dcfeda672baa459b14ba2c3 |
IEDL.DBID | DR2 |
ISSN | 1464-4096 1464-410X |
IngestDate | Fri Jul 11 16:39:23 EDT 2025 Fri Jul 11 01:49:47 EDT 2025 Thu Apr 03 07:07:08 EDT 2025 Wed Apr 02 07:15:04 EDT 2025 Thu Apr 24 22:54:26 EDT 2025 Tue Jul 01 03:49:58 EDT 2025 Wed Jan 22 16:52:39 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Kidney disease Human Urine Nephrology Urinary system disease Calciuria Calcium lithogenic activity Citrate Inorganic element urinary calcium: citrate ratio Biological activity Urology Urinary stone Osteoarticular system urinary citrate Renal lithiasis Ratio Bone Severe |
Language | English |
License | CC BY 4.0 2012 BJU International. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4332-2dd1bcd9ea2c9f15c47843541f4c43d930abf7ef71dcfeda672baa459b14ba2c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 22757744 |
PQID | 1324384272 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1352283957 proquest_miscellaneous_1324384272 pubmed_primary_22757744 pascalfrancis_primary_27220563 crossref_citationtrail_10_1111_j_1464_410X_2012_11292_x crossref_primary_10_1111_j_1464_410X_2012_11292_x wiley_primary_10_1111_j_1464_410X_2012_11292_x_BJU11292 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2013 |
PublicationDateYYYYMMDD | 2013-04-01 |
PublicationDate_xml | – month: 04 year: 2013 text: April 2013 |
PublicationDecade | 2010 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford – name: England |
PublicationTitle | BJU international |
PublicationTitleAlternate | BJU Int |
PublicationYear | 2013 |
Publisher | Wiley-Blackwell |
Publisher_xml | – name: Wiley-Blackwell |
References | 1994; 9 2010; 76 2010; 42 1991; 19 2011; 108 1991; 58 2002; 168 2003; 8 2006; 59 2005; 63 2005; 31 2011; 33 2003; 16 1996; 73 2000; 164 2007; 60 1998; 50 2007; 34 2005; 55 1990; 83 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 Audran M (e_1_2_7_21_1) 1991; 58 e_1_2_7_3_1 Simic‐Ogrizovic S (e_1_2_7_7_1) 2007; 60 e_1_2_7_9_1 e_1_2_7_8_1 Mithani S (e_1_2_7_12_1) 2005; 55 e_1_2_7_18_1 e_1_2_7_17_1 Arrabal Martin M (e_1_2_7_2_1) 2006; 59 Batista Peres LA (e_1_2_7_14_1) 2011; 33 e_1_2_7_13_1 e_1_2_7_23_1 e_1_2_7_11_1 e_1_2_7_22_1 e_1_2_7_10_1 Giannini S (e_1_2_7_19_1) 1998; 50 Caudarella R (e_1_2_7_20_1) 2003; 16 Höbarth K (e_1_2_7_16_1) 1991; 19 Hofbauer J (e_1_2_7_15_1) 1990; 83 22757770 - BJU Int. 2013 Apr;111(4):529-30 |
References_xml | – volume: 60 start-page: 117 year: 2007 end-page: 120 article-title: The most important factor for active urinary stone formation in patients with urolithiasis publication-title: Med Pregl – volume: 31 start-page: 29 year: 2005 end-page: 33 article-title: Metabolic assessment in patients with urinary lithiasis publication-title: Int Braz J Urol – volume: 33 start-page: 34 year: 2011 end-page: 38 article-title: Nephrolithiasis in pediatric patients: metabolic and anatomical investigation publication-title: J Bras Nefrol – volume: 59 start-page: 583 year: 2006 end-page: 594 article-title: Study of the physical‐chemical factors in patients with renal lithiasis publication-title: Arch Esp Urol – volume: 164 start-page: 162 year: 2000 end-page: 165 article-title: A study of the etiology of idiopathic calcium urolithiasis in children: hypocitraturia is the most important risk factor publication-title: J Urol – volume: 63 start-page: 188 year: 2005 end-page: 192 article-title: Risk factors determining active urinary stone formation in patients with urolithiasis publication-title: Clin Nephrol – volume: 76 start-page: 242 year: 2010 end-page: 246 article-title: The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate publication-title: Urology – volume: 58 start-page: 747 year: 1991 end-page: 750 article-title: Bone density in idiopathic hypercalciuria in men. Study by dual photon absorptiometry, X‐ray computed tomography and histomorphometry publication-title: Rev Rhum Mal Osteoartic – volume: 9 start-page: 1525 year: 1994 end-page: 1532 article-title: Low bone mass in idiopathic renal stone formers: magnitude and significance publication-title: J Bone Miner Res – volume: 42 start-page: 127 year: 2010 end-page: 131 article-title: Metabolic abnormalities in patients with nephrolithiasis: comparison of first‐episode with recurrent cases in Southern Iran publication-title: Int Urol Nephrol – volume: 16 start-page: 260 year: 2003 end-page: 266 article-title: Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors publication-title: J Nephrol – volume: 108 start-page: 1903 year: 2011 end-page: 1908 article-title: Mineral density and bone remodelling markers in patients with calcium lithiasis publication-title: BJU Int – volume: 83 start-page: 597 year: 1990 end-page: 602 article-title: The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi publication-title: Z Urol Nephrol – volume: 76 start-page: 238 year: 2010 end-page: 241 article-title: Metabolic evaluation in stone disease metabolic differences between the pediatric and adult patients with stone disease publication-title: Urology – volume: 34 start-page: 323 year: 2007 end-page: 334 article-title: Pathophysiology and management of calcium stones publication-title: Urol Clin North Am – volume: 168 start-page: 31 year: 2002 end-page: 34 article-title: Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis publication-title: J Urol – volume: 73 start-page: 557 year: 1996 end-page: 560 article-title: Bone mineral density in patients with hypercalciuric nephrolithiasis publication-title: Nephron – volume: 50 start-page: 94 year: 1998 end-page: 100 article-title: Bone density and skeletal metabolism are altered in idiopathic hypercalciuria publication-title: Clin Nephrol – volume: 55 start-page: 371 year: 2005 end-page: 373 article-title: Comparison of 24 hours urinary citrate levels in urolithiasis patients and healthy controls publication-title: J Pak Med Assoc – volume: 8 start-page: s1084 year: 2003 end-page: 1086 article-title: Citrate and mineral metabolism: kidney stones and bone disease publication-title: Front Biosci – volume: 34 start-page: 315 year: 2007 end-page: 322 article-title: Evaluation of the recurrent stone former publication-title: Urol Clin North Am – volume: 19 start-page: 165 year: 1991 end-page: 168 article-title: Value of routine citrate analysis and calcium/citrate ration in calcium urolithiasis publication-title: Eur Urol – ident: e_1_2_7_18_1 doi: 10.2741/1119 – ident: e_1_2_7_3_1 doi: 10.1590/S1677-55382005000100006 – volume: 83 start-page: 597 year: 1990 ident: e_1_2_7_15_1 article-title: The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi publication-title: Z Urol Nephrol – ident: e_1_2_7_11_1 doi: 10.1007/s11255-009-9599-9 – ident: e_1_2_7_22_1 doi: 10.1159/000189140 – volume: 58 start-page: 747 year: 1991 ident: e_1_2_7_21_1 article-title: Bone density in idiopathic hypercalciuria in men. Study by dual photon absorptiometry, X‐ray computed tomography and histomorphometry publication-title: Rev Rhum Mal Osteoartic – ident: e_1_2_7_8_1 doi: 10.1016/j.ucl.2007.04.007 – ident: e_1_2_7_10_1 doi: 10.1016/j.ucl.2007.04.009 – ident: e_1_2_7_23_1 doi: 10.1002/jbmr.5650091004 – ident: e_1_2_7_6_1 doi: 10.1016/S0022-5347(05)67487-3 – volume: 55 start-page: 371 year: 2005 ident: e_1_2_7_12_1 article-title: Comparison of 24 hours urinary citrate levels in urolithiasis patients and healthy controls publication-title: J Pak Med Assoc – volume: 59 start-page: 583 year: 2006 ident: e_1_2_7_2_1 article-title: Study of the physical‐chemical factors in patients with renal lithiasis publication-title: Arch Esp Urol – volume: 16 start-page: 260 year: 2003 ident: e_1_2_7_20_1 article-title: Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors publication-title: J Nephrol – ident: e_1_2_7_9_1 doi: 10.1111/j.1464-410X.2011.10167.x – volume: 33 start-page: 34 year: 2011 ident: e_1_2_7_14_1 article-title: Nephrolithiasis in pediatric patients: metabolic and anatomical investigation publication-title: J Bras Nefrol – volume: 60 start-page: 117 year: 2007 ident: e_1_2_7_7_1 article-title: The most important factor for active urinary stone formation in patients with urolithiasis publication-title: Med Pregl – ident: e_1_2_7_4_1 doi: 10.5414/CNP63188 – volume: 19 start-page: 165 year: 1991 ident: e_1_2_7_16_1 article-title: Value of routine citrate analysis and calcium/citrate ration in calcium urolithiasis publication-title: Eur Urol doi: 10.1159/000473606 – volume: 50 start-page: 94 year: 1998 ident: e_1_2_7_19_1 article-title: Bone density and skeletal metabolism are altered in idiopathic hypercalciuria publication-title: Clin Nephrol – ident: e_1_2_7_13_1 doi: 10.1016/j.urology.2009.09.084 – ident: e_1_2_7_5_1 doi: 10.1016/j.urology.2010.01.036 – ident: e_1_2_7_17_1 doi: 10.1016/S0022-5347(05)64825-2 – reference: 22757770 - BJU Int. 2013 Apr;111(4):529-30 |
SSID | ssj0014665 |
Score | 2.1757395 |
Snippet | What's known on the subject? and What does the study add?
Different studies have shown the importance of citrate in the formation of calcium stones. It has... Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 622 |
SubjectTerms | Adult Biological and medical sciences Biomarkers - analysis bone Bone Density Calcium - metabolism Calcium - urine Calculi - chemistry Citric Acid - metabolism Citric Acid - urine Confidence Intervals Creatinine - urine Cross-Sectional Studies Decalcification, Pathologic - physiopathology Female Humans Incidence Linear Models lithogenic activity Logistic Models Male Medical sciences Middle Aged Multivariate Analysis Nephrolithiasis - diagnosis Nephrolithiasis - epidemiology Nephrolithiasis - urine Nephrology. Urinary tract diseases Odds Ratio Predictive Value of Tests Prognosis Risk Assessment ROC Curve Severity of Illness Index Spain Urinalysis urinary calcium : citrate ratio urinary citrate Urinary lithiasis |
Title | Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-410X.2012.11292.x https://www.ncbi.nlm.nih.gov/pubmed/22757744 https://www.proquest.com/docview/1324384272 https://www.proquest.com/docview/1352283957 |
Volume | 111 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh1Iobfrepg0q9OpFkmV5nVtbGtJAeihd2JvQszVJvGG9CyWnXvs380s6I9tbHEIJpQeDsWcsS56RPsmjbwh56xSP3Fchswa8SSpmM8ucyBSDDjkyz4TDdciTz-poLo8XxaKPf8K9MB0_xHbBDT0j9dfo4Ma2151cZpKzBUZoCdwMU4kp4kkM3UJ89GXLJAWiKatkpwKwfRzUc-ODRiPV_QvTQqPFLtvFTXB0jG7T8HT4kJwOFeuiUk6nm7WdustrnI__p-a75EGPYum7zuwekTuheUzunvT_6Z-Qy0_nCdeDRdFlpK5OHLjUNJ4C4KRQRVdvzq9-_jqAY7ibbJHWDe25XluKi8SDMF0FLBJmDd9r09ZtehgM62EV0sXlN-y16_YpmR9-_PrhKOuzPGQOudMy4T23DszFCFdFXjhZzgDDSR4lCPgqZ8bGMsSSexeDN6oU1hhZVJZLCzr5M7LTLJvwglCroP-RyisLyj6PMw_zXxatZ8z4WBQTUg5fVLueAh0zcZzp0VRIamxajU2rU9PqHxPCt5oXHQ3ILXT2R0azVRQl7m5W-YS8GaxIg1PjnxrThOWm1Rxgbj6TIPg3mQKpi6qinJDnnQn-KUGUBeB6CRVOhnTrd9bvj-fp9OU_a-6ReyKlDMHopldkZ73ahNcA3NZ2P7nkb9fgN4Y |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9QwFA6yggri_TJe1gi-dkjStJ36puIyu-7sg-zAvIVctbjbWaYzIPvkq3_TX-I5aTvSZZFFfCiU9pykSc9Jvty-Q8gbm_PAXekTo8GbZM5MYpgVSc6gQQ7MMWFxHnJ2lE_n8mCRLbpwQHgWpuWH2E64oWfE9hodHCekL3q5TCRnC9yiJfA0TCnGACivY4DvOL76vOWSAtkYV7LVAeA-3NZzaUqDvur2mW6g2kIb7-IyQDrEt7GD2rtLTvqitftSvo03azO25xdYH_9T2e-ROx2Qpe9ay7tPrvn6Abkx65bqH5Lz_dMI7cGo6DJQW0UaXKprRwFzUiijrTanv378fAtX_zaaI61q2tG9NhTniXthuvKYJQwcvla6qZqYGPTsfuXjw-UXbLir5hGZ7308_jBNukAPiUX6tEQ4x40Fi9HCloFnVhYTgHGSBwkCrkyZNqHwoeDOBu90XgijtcxKw6UBnfQx2amXtX9KqMmhCZK5yw0ouzRMHAyBWTCOMe1Clo1I0f9SZTsWdAzGcaIGoyGpsGoVVq2KVau-jwjfap61TCBX0NkdWM1WURR4wDlPR-R1b0YK_BoXa3Ttl5tGcUC66USC4N9kMmQvKrNiRJ60NvgnB1FkAO0lFDha0pW_Wb0_mMfbZ_-s-YrcnB7PDtXh_tGn5-SWiBFEcLPTC7KzXm38S8Bxa7Mb_fM3PJI7oQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlgVAo6bvdpk1V6NWLJMvyure26ZKkTSilC3sTeqYmjXdZ70LIKdf-zf6SjGR7i0MoofRgMPaMZcnfSJ_k0QxCb42gntrCJVqBNXFBdKKJYYkg0CF7YgkzYR3y6FjsT_jhNJu2_k9hL0wTH2K94BYsI_bXwcDn1l83cp5wSqbBQ4uFzTAFGwKf3IQiRwHhe9_WoaRANqaVbHSAt_e9em58Um-oujdXNbSab9Jd3MRH-_Q2jk_j--i0q1njlnI6XC310FxcC_r4f6r-AG23NBa_b3D3EN1x1SO0ddT-qH-MLg7OIrEHSOGZx6aMQXCxqiwGxomhiqZcnf2-_PUOju5uBCMuK9wGe61xWCXuhPHChSJh2vCjVHVZx4fBuO4WLl6cnYRuu6yfoMn40_eP-0mb5iExIXhawqyl2gBeFDOFp5nh-QhIHKeeg4AtUqK0z53PqTXeWSVyppXiWaEp16CTPkUb1axyzxHWAjogLqzQoGxTP7IwASZeW0KU9Vk2QHn3RaVpY6CHVBw_ZW8uxGVoWhmaVsamlecDRNea8yYOyC10dnugWSuyPGxvFukAvelQJMGqw68aVbnZqpYUeG464iD4N5ksxC4qsnyAnjUQ_FMCyzMg9hwqHIF063eWHw4n8fTFP2u-Rltf98byy8Hx5x10l8X0IcHT6SXaWC5W7hWQuKXejdZ5BXHmOlk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Importance+of+citrate+and+the+calcium%E2%80%89%3A%E2%80%89citrate+ratio+in+patients+with+calcium+renal+lithiasis+and+severe+lithogenesis&rft.jtitle=BJU+international&rft.au=Arrabal%E2%80%90Polo%2C+Miguel+Angel&rft.au=Arrabal%E2%80%90Martin%2C+Miguel&rft.au=Arias%E2%80%90Santiago%2C+Salvador&rft.au=Garrido%E2%80%90Gomez%2C+Juan&rft.date=2013-04-01&rft.issn=1464-4096&rft.eissn=1464-410X&rft.volume=111&rft.issue=4&rft.spage=622&rft.epage=627&rft_id=info:doi/10.1111%2Fj.1464-410X.2012.11292.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1464_410X_2012_11292_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon |